Please try another search
As of September 23, 2014, CFR Pharmaceuticals S.A. was acquired by Abbott Laboratories. CFR Pharmaceuticals S.A., a pharmaceutical company, engages in the research, development, manufacture, and commercialization of specialty branded generics and complex injectables. Its portfolio comprises products for the treatment of approximately 200 diseases and for general health care. The company offers specialty pharma products comprising women’s health, neurology, psychiatry, general medicine, pneumology, otorhinolaryngology, allergies, cardiology, dermatology, ophthalmology, and generic products. It also provides complex therapeutic drugs for the treatment of complex illnesses consisting sterile injectable products and lyophilized forms for anesthesia, infections, cardiology, and intensive care; and biological products, monoclonal antibodies, and treatments for dialysis, transplants, oncology, and rheumatology. In addition, the company offers over-the-counter products, nutrition products, food supplements, and homeopathic products. It operates in approximately 18 countries in the Americas, Europe, and Asia. The company was founded in 1922 and is based in Providencia, Chile.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review